X

Vous n'êtes pas connecté

Maroc Maroc - NEWS.MEDICAL.NET - A la Une - 30/Jul 04:39

Evidence lacking for widespread youth psychotropic prescribing

There's limited evidence to back up the widespread and increasing rates of prescribing mood-altering drugs (psychotropics) as the mainstay of mental health treatment for children and young people, warn experts in an editorial, published in the August issue of Drug and Therapeutics Bulletin (dtb)

Articles similaires

Sorry! Image not available at this time

FDA Grants Priority Review to SpringWorks Therapeutics’ New Drug Application for Mirdametinib for the Treatment of Adults and Children with NF1-PN

drugs.com - 28/Aug 01:09

STAMFORD, Conn., Aug. 28, 2024 (GLOBE NEWSWIRE) -- SpringWorks Therapeutics, Inc. (Nasdaq: SWTX), a commercial-stage biopharmaceutical company focused...

Research highlights media misrepresentation of COVID-19 drug efficacy

news.medical.net - 30/Aug 14:19

A new study from researchers at Wake Forest University School of Medicine is shedding light on how scientific evidence and the uncertainty surrounding...

Sorry! Image not available at this time

COMMENT: Emulate John Landa Nkomo Trust in tackling drug menace

chronicle.co.zw - 01/Sep 22:05

REPRESENTATIVES of youth and sport groups from Bolivia, Norway, Kenya, Bermuda, Spain, and Italy gathered for a workshop in 2001 to discuss the use of...

Unapproved formulations accounted for over 60 pc of psychotropic FDCs from 2008-2020: Study

times of india - 01/Sep 06:29

A study found unapproved formulations accounted for over 60% of psychotropic fixed dose combination drug sales in India from 2008 to 2020. The report...

Sorry! Image not available at this time

FG Warns Youths against Drug Addiction

nporeports.com - 01/Sep 06:37

 Agency Report The Federal Government on Saturday warned youths against getting involved in illicit drugs, as it is dangerous and inimical to human...

Sorry! Image not available at this time

Soleno Therapeutics Announces U.S. FDA Acceptance for Filing and Priority Review of NDA for DCCR (Diazoxide Choline) Extended-Release Tablets in Prader-Willi Syndrome

drugs.com - 27/Aug 05:08

REDWOOD CITY, Calif., Aug. 27, 2024 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO), a clinical-stage biopharmaceutical...

Promising treatment for rectal cancer confirmed in major study

oncologynews.com.au - 26/Aug 13:04

A new treatment for locally advanced rectal cancer shows favourable results in that surgery can sometimes be avoided completely. It also reduces the...

Sorry! Image not available at this time

Singulair warnings OK’d

courthousenews.com - 28/Aug 13:51

OAKLAND, Calif. — Merck & Co., the pharmacology giant that manufactures the anti-inflammatory treatment montelukast aka Singulair, defeated...

Sorry! Image not available at this time

Why common diabetes drug metformin can help you live longer

knowridge.com - 10:31

Delirium is a serious condition that can cause confusion and disorientation, usually appearing suddenly and often due to illness, surgery, or...

Sorry! Image not available at this time

MindBio advances world-first psychedelic microdosing clinical trials

themarketherald.ca - 29/Aug 14:44

MindBio Therapeutics (CSE:MBIO) announces the successful completion of its Phase 1 and 2a clinical trials on depression treatment.

Les derniers communiqués

  • Aucun élément